Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer
Clinical trial NCT00677924 · TERMINATED
Trial details
- NCT number
- NCT00677924
- Sponsor
- Genmab
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2009-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.